July 11, 2022
Differentiating NMOSD From MS With Machine Learning
There is an unmet need to differentiate NMOSD from MS due to the potential effects and safety risks associated with executing the wrong treatment regimen. Infrared spectroscopy coupled with a machine learning algorithm may be a promising point-of-care diagnostic tool. Establishing a diagnosis of neuromyelitis optica spectrum disorder (NMOSD) differentiated from multiple sclerosis (MS) is...
Differentiating MS from NMOSD Via Imaging Criteria
Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein antibody (MOG-Ab)-associated disease (MOGAD) present with overlapping features, which can make a differential diagnosis difficult. Brain and spinal cord magnetic resonance imaging (MRI) is an appropriate method for determining a correct diagnosis. The overlapping clinical features of multiple sclerosis (MS), neuromyelitis optica spectrum...
Persistent Racial Disparities in NMOSD and MS Clinical Trial Enrollment
Calls for parity in clinical trial enrollment among all racial groups, especially Blacks and Hispanics, are being advocated. Considering the aggressive progression of disease in racial and ethnic groups, more drug research is needed in racial groups who may be at higher risk of complications than others. Neuromyelitis optica spectrum disorder (NMOSD) is a progressive,...